Advances in the treatment of childhood cancers have resulted in part from the development
of national and international collaborative initiatives that have defined biologic determinants …

Acute lymphoblastic leukemia in low and middle-income countr... : Current Opinion in Oncology
Acute lymphoblastic leukemia in low and middle-income countries: disease characteristics and …

Acute lymphoblastic leukaemia (ALL) is the most common childhood cancer and has a high
survival rate when properly managed. Prognosis is correlated with many factors such as …

Background Children with relapsed acute lymphoblastic leukemia (ALL) in low‐income and
middle‐income countries rarely survive. The Pediatric Hematology‐Oncology Association of …

Background Repeated high-dose methotrexate (HDMTX) is a critical component of
contemporary childhood acute lymphoblastic leukemia (ALL) treatment regimens. Serum …

Acute lymphoblastic leukemia (ALL) is the most common malignancy among children.
Although studies have shown that malnutrition can negatively affect treatment outcome …

Background Armed conflict can disrupt oncology care profoundly, resulting in worsened
health outcomes for cancer patients. Syria has endured armed conflict for over a decade …

Introduction The identification of aberrancies in leukemia‐associated immunophenotype
(LAIP) of acute lymphoblastic leukemia (ALL) is quite important in the assessment of minimal …

PURPOSE The global pediatric oncology clinical research landscape, particularly in Central
and South America, Africa, and Asia, which bear the highest burden of global childhood …

Background Leukemia is the main malignant hematologic disease of children with different
oral manifestations and clinical features. Attention to the oral manifestations is essential for …